These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 12370274

  • 1. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II.
    Wang L, Soroka CJ, Boyer JL.
    J Clin Invest; 2002 Oct; 110(7):965-72. PubMed ID: 12370274
    [Abstract] [Full Text] [Related]

  • 2. Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.
    Kagawa T, Watanabe N, Mochizuki K, Numari A, Ikeno Y, Itoh J, Tanaka H, Arias IM, Mine T.
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G58-67. PubMed ID: 17947449
    [Abstract] [Full Text] [Related]

  • 3. Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II.
    Wang L, Dong H, Soroka CJ, Wei N, Boyer JL, Hochstrasser M.
    Hepatology; 2008 Nov; 48(5):1558-69. PubMed ID: 18798335
    [Abstract] [Full Text] [Related]

  • 4. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11.
    Hayashi H, Takada T, Suzuki H, Akita H, Sugiyama Y.
    Hepatology; 2005 Apr; 41(4):916-24. PubMed ID: 15791618
    [Abstract] [Full Text] [Related]

  • 5. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
    Hayashi H, Sugiyama Y.
    Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
    [Abstract] [Full Text] [Related]

  • 6. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
    Hayashi H, Sugiyama Y.
    Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
    [Abstract] [Full Text] [Related]

  • 7. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.
    Lam P, Pearson CL, Soroka CJ, Xu S, Mennone A, Boyer JL.
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1709-16. PubMed ID: 17855769
    [Abstract] [Full Text] [Related]

  • 8. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J, Ellinger P, Weissenberger K, Dröge C, Herebian D, Mayatepek E, Homey B, Braun S, Schulte am Esch J, Horacek M, Canbay A, Schmitt L, Häussinger D, Kubitz R.
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [Abstract] [Full Text] [Related]

  • 9. A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump.
    Plass JR, Mol O, Heegsma J, Geuken M, de Bruin J, Elling G, Müller M, Faber KN, Jansen PL.
    J Hepatol; 2004 Jan; 40(1):24-30. PubMed ID: 14672610
    [Abstract] [Full Text] [Related]

  • 10. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.
    Noe J, Kullak-Ublick GA, Jochum W, Stieger B, Kerb R, Haberl M, Müllhaupt B, Meier PJ, Pauli-Magnus C.
    J Hepatol; 2005 Sep; 43(3):536-43. PubMed ID: 16039748
    [Abstract] [Full Text] [Related]

  • 11. Bile salt export pump is highly conserved during vertebrate evolution and its expression is inhibited by PFIC type II mutations.
    Cai SY, Wang L, Ballatori N, Boyer JL.
    Am J Physiol Gastrointest Liver Physiol; 2001 Aug; 281(2):G316-22. PubMed ID: 11447010
    [Abstract] [Full Text] [Related]

  • 12. Discovery and structural development of small molecules that enhance transport activity of bile salt export pump mutant associated with progressive familial intrahepatic cholestasis type 2.
    Misawa T, Hayashi H, Sugiyama Y, Hashimoto Y.
    Bioorg Med Chem; 2012 May 01; 20(9):2940-9. PubMed ID: 22464344
    [Abstract] [Full Text] [Related]

  • 13. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
    Ellinger P, Stindt J, Dröge C, Sattler K, Stross C, Kluge S, Herebian D, Smits SHJ, Burdelski M, Schulz-Jürgensen S, Ballauff A, Schulte Am Esch J, Mayatepek E, Häussinger D, Kubitz R, Schmitt L.
    World J Gastroenterol; 2017 Aug 07; 23(29):5295-5303. PubMed ID: 28839429
    [Abstract] [Full Text] [Related]

  • 14. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
    Kubitz R, Dröge C, Kluge S, Stross C, Walter N, Keitel V, Häussinger D, Stindt J.
    Clin Rev Allergy Immunol; 2015 Jun 07; 48(2-3):273-84. PubMed ID: 25342496
    [Abstract] [Full Text] [Related]

  • 15. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
    Jansen PL, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJ, Koning JH, De Jager-Krikken A, Kuipers F, Stellaard F, Bijleveld CM, Gouw A, Van Goor H, Thompson RJ, Müller M.
    Gastroenterology; 1999 Dec 07; 117(6):1370-9. PubMed ID: 10579978
    [Abstract] [Full Text] [Related]

  • 16. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
    Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerová D, Rayner A, Dutton L, Meier Y, Antoniou A, Stieger B, Arnell H, Ozçay F, Al-Hussaini HF, Bassas AF, Verkade HJ, Fischler B, Németh A, Kotalová R, Shneider BL, Cielecka-Kuszyk J, McClean P, Whitington PF, Sokal E, Jirsa M, Wali SH, Jankowska I, Pawłowska J, Mieli-Vergani G, Knisely AS, Bull LN, Thompson RJ.
    Gastroenterology; 2008 Apr 07; 134(4):1203-14. PubMed ID: 18395098
    [Abstract] [Full Text] [Related]

  • 17. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
    Gonzales E, Grosse B, Schuller B, Davit-Spraul A, Conti F, Guettier C, Cassio D, Jacquemin E.
    Hepatology; 2015 Aug 07; 62(2):558-66. PubMed ID: 25716872
    [Abstract] [Full Text] [Related]

  • 18. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
    Keitel V, Burdelski M, Vojnisek Z, Schmitt L, Häussinger D, Kubitz R.
    Hepatology; 2009 Aug 07; 50(2):510-7. PubMed ID: 19642168
    [Abstract] [Full Text] [Related]

  • 19. Ursodeoxycholic acid stabilizes the bile salt export pump in the apical membrane in MDCK II cells.
    Kagawa T, Orii R, Hirose S, Arase Y, Shiraishi K, Mizutani A, Tsukamoto H, Mine T.
    J Gastroenterol; 2014 May 07; 49(5):890-9. PubMed ID: 23722250
    [Abstract] [Full Text] [Related]

  • 20. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells.
    Harris MJ, Kagawa T, Dawson PA, Arias IM.
    J Gastroenterol Hepatol; 2004 Jul 07; 19(7):819-25. PubMed ID: 15209631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.